Last data update: Nov 30, 2022. (Total: 4113 publications since 2011)
|Query Trace: all>>Du-Ping Zheng[CDC Author]|
| High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study.
Janet Gare, Ben Toto, Percy Pokeya, Linh-Vi Le, Nick Dala, Namarola Lote, Bangan John, Abel Yamba, Kevin Soli, Joshua DeVos, Heather Paulin, Nick Wagar, Du-Ping Zheng, Takeshi Nishijima, Peniel Boas, Angela Kelly-Hanku, and Anup Gurung
BMC infectious diseases 2022 22(1) 266
Similar articles in PubMed DOI:10.1186/s12879-022-07264-y
| Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy.
Zhiyong Zhou, Kevin Tang, Guoqing Zhang, Nellie Wadonda-Kabondo, Kundai Moyo, Lori A Rowe, Joshua R DeVos, Nick Wagar, Du-Ping Zheng, Hongxiong Guo, John Nkengasong, Mike Frace, Scott Sammons, and Chunfu Yang
African journal of laboratory medicine 2018 (1) 708
Similar articles in PubMed DOI:10.4102/ajlm.v7i1.708
| Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance.
Du-Ping Zheng, Margarida Rodrigues, Ebi Bile, Duc B Nguyen, Karidia Diallo, Joshua R DeVos, John N Nkengasong, and Chunfu Yang
PLoS ONE 2013 8(10) e77649
Similar articles in PubMed DOI:10.1371/journal.pone.0077649
| Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.
Karidia Diallo, Du-Ping Zheng, Erin K Rottinghaus, Orji Bassey, and Chunfu Yang
AIDS Res. Hum. Retroviruses 2015 May (5) 564-75
Similar articles in PubMed DOI:10.1089/AID.2014.0168